The anti-tumor effects of an adenoviral vaccine expressing 4-1BB ligand in a murine melanoma model

被引：0

作者：

Ragonnaud, E. ^{[1
]}

Andersson, A. ^{[1
]}

Jensen, B. A. H. ^{[1
]}

Thomsen, A. R. ^{[1
]}

Holst, P. J. ^{[1
]}

机构：

[1] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark

来源：

IMMUNOLOGY | 2012年 / 137卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：723 / 723

页数：1

共 50 条

[31] Nano-Emulsion Based WT1 DNA Vaccine Elicits Significant Anti-Tumor Response in a Murine Model of Melanoma
Chattopadhyay, Sourav
Khan, Nusrat
Sujanthi, E.
Jayandharan, Giridhara R.
MOLECULAR THERAPY, 2019, 27 (04) : 273 - 273
[32] DUAL-TARGETING OF 4-1BB AND OX40 WITH AN ADAPTIR™ BISPECIFIC ANTIBODY ENHANCES ANTI-TUMOR RESPONSES TO SOLID TUMOR
Nelson, Michelle
Miller, Robert
Blahnik-Fagan, Gabriele
Loh, Lauren
Van Citters, Danielle
Misher, Lynda
Sprague, Megan
Dasovich, Maria
Barber, Irene
Maggiora, Kathy
Gruswitz, Franz
Woodruff, Brian
Huntington, Kelsey
Guinn, Aelish
Aguilar, Megan
Daugherty, Mollie
Haglin, Elizabeth
Gross, Jane
Pavlik, Peter
McMahan, Catherine
Bienvenue, David
Hernandez-Hoyos, Gabriela
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A379 - A380
[33] 4-1BB Aptamer-Based Immunomodulation Enhances the Efficacy of Ionizing Radiation in a Preclinical Murine Tumor Model
Brenneman, R.
Sullivan, E. J.
Berezhnoy, A.
Ishkanian, F.
Gilboa, E.
Pollack, A.
Ishkanian, A. S.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S176 - S176
[34] LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model.
Huang, Xiao
Sun, Jianming
Qin, Yurong
Lin, Huan
Guan, Jing
Lai, Shoupeng
Kang, Xiaoqiang
Ling, Hong
CANCER RESEARCH, 2021, 81 (13)
[35] ATG-101, A NOVEL PD-L1/4-1BB BISPECIFIC ANTIBODY, AUGMENTS ANTI-TUMOR IMMUNITY THROUGH IMMUNE CHECKPOINT INHIBITION AND PDL1-DIRECTED 4-1BB ACTIVATION
Hui Yuwen
Li, Tengteng
Ren, Yijing
Hoenemann, Dirk
Mei, Jay
Shan, Bo
Hou, Bing
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A936 - A937
[36] 4-1BB Costimulation as an Adjuvant for HIV-1 DNA Vaccine: Different Effects by Anti-4-1BB Agonist Ab and 4-1BBL DNA
Ganguly, S.
Liu, J.
Mittler, R.
Amara, R.
VACCINE, 2008,
[37] KEY PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS THAT CORRELATE WITH THE ANTI-TUMOR ACTIVITY OF A BISPECIFIC PD-L1 CONDITIONAL 4-1BB AGONIST
Kinkead, Heather
Macedo, Chelsie
Sanabria, Angelica
Cyprus, Garrett
Pandit, Rajay
Kalabus, James
Becklund, Bryan
Sulzmaier, Florian
Timmer, John
Deveraux, Quinn
Eckelman, Brendan
Heidt, Analeah
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A12 - A12
[38] Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity
Hangiu, Oana
Compte, Marta
Dinesen, Anders
Navarro, Rocio
Tapia-Galisteo, Antonio
Mandrup, Ole A.
Erce-Llamazares, Ainhoa
Lazaro-Gorines, Rodrigo
Nehme-Alvarez, Daniel
Dominguez-Alonso, Carmen
Harwood, Seandean L.
Alfonso, Carlos
Blanco, Belen
Rubio-Perez, Laura
Jimenez-Reinoso, Anais
Diez-Alonso, Laura
Blanco, Francisco J.
Sanz, Laura
Howard, Kenneth A.
Alvarez-Vallina, Luis
ISCIENCE, 2022, 25 (09)
[39] A bispecific antibody targeting CLDN18.2 and 4-1BB induces potent anti-tumor efficacy with an extraordinary safety profile
Chen, Junying
Huang, Weifeng
Liang, Zhiquan
Miao, Xiaoniu
Peng, Shaogang
Wang, Chao
Dong, Tiantian
Tsun, Andy
Luo, Yi
CANCER RESEARCH, 2022, 82 (12)
[40] A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer
Geng, Fei
Guo, Jie
Guo, Qian-Qian
Xie, Yu
Dong, Ling
Zhou, Yi
Liu, Chen-Lu
Yu, Bin
Wu, Hui
Wu, Jia-Xin
Zhang, Hai-Hong
Kong, Wei
Yu, Xiang-Hui
VACCINE, 2019, 37 (31) : 4382 - 4391

← 1 2 3 4 5 →